AAPL 169.89 0.5147% MSFT 399.04 -2.4495% GOOG 157.95 -1.9553% GOOGL 156.0 -1.9669% AMZN 173.67 -1.6535% NVDA 826.32 3.7087% META 441.38 -10.5613% TSLA 170.18 4.9652% TSM 136.58 2.7149% LLY 724.87 -1.0011% V 275.16 0.0509% AVGO 1294.42 2.9917% JPM 193.37 0.1502% UNH 493.86 1.3462% NVO 125.79 -0.2933% WMT 60.21 0.5679% LVMUY 167.91 -2.1618% XOM 121.35 0.2478% LVMHF 837.0 -2.6461% MA 462.11 -0.0843%
Last update at 2024-04-25T20:14:00Z
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | -13663.34300M | -384.65600M | -575.99300M | -109.45500M | -96.96600M |
Minority interest | - | - | - | - | - |
Net income | -13659.53100M | -428.79300M | -485.13600M | -98.86400M | -97.08400M |
Selling general administrative | 449.86M | 438.01M | 506.68M | 164.46M | 118.78M |
Selling and marketing expenses | 850.71M | 667.31M | 380.20M | 174.61M | 144.26M |
Gross profit | 1662.85M | 1382.45M | 703.13M | 368.84M | 289.17M |
Reconciled depreciation | 270.64M | 219.62M | 78.09M | 44.95M | 35.60M |
Ebit | -13739.76800M | -238.98800M | -418.18500M | -73.82200M | -65.96300M |
Ebitda | -13469.12500M | -14.27900M | -340.09800M | -28.87000M | -30.36100M |
Depreciation and amortization | 270.64M | 224.71M | 78.09M | 44.95M | 35.60M |
Non operating income net other | -0.85900M | -38.66000M | -9.07700M | - | - |
Operating income | -13198.48200M | -238.98800M | -418.18500M | -73.82200M | -70.85400M |
Other operating expenses | 2634.21M | 2271.70M | 1512.15M | 627.13M | 483.87M |
Interest expense | 9.27M | 80.36M | 60.49M | 29.01M | 26.11M |
Tax provision | -3.81200M | 44.14M | -90.85700M | -10.59100M | 0.12M |
Interest income | - | - | - | 29.01M | 26.11M |
Net interest income | -9.27000M | -80.36500M | -60.49500M | -29.01300M | -26.11200M |
Extraordinary items | - | - | - | - | - |
Non recurring | 13425.85M | 26.64M | 88.24M | 6.62M | 12.26M |
Other items | - | - | - | - | - |
Income tax expense | -3.81200M | 44.14M | -90.85700M | -10.59100M | 0.12M |
Total revenue | 2406.84M | 2032.71M | 1093.96M | 553.31M | 417.91M |
Total operating expenses | 1890.22M | 1621.44M | 1121.32M | 442.66M | 355.13M |
Cost of revenue | 743.99M | 650.26M | 390.83M | 184.47M | 128.74M |
Total other income expense net | -26861.82500M | -145.66800M | -157.80800M | -35.63300M | -4.89100M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | -13659.53100M | -428.79300M | -485.13600M | -98.86400M | -97.08400M |
Net income applicable to common shares | -13659.53100M | -428.79300M | -485.13600M | -98.86400M | -97.08400M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Total assets | 4345.35M | 17734.61M | 17755.28M | 1602.83M | 1528.88M |
Intangible assets | 1836.77M | 1910.28M | 2020.86M | 225.45M | 247.39M |
Earning assets | - | - | - | - | - |
Other current assets | 130.31M | 87.39M | 47.26M | 13.99M | 10.63M |
Total liab | 2037.61M | 1688.85M | 1871.48M | 588.80M | 515.76M |
Total stockholder equity | 2307.74M | 16045.76M | 15883.80M | 1014.02M | 1013.12M |
Deferred long term liab | 54.81M | 2.40M | 104.55M | 21.68M | 32.44M |
Other current liab | 248.03M | 195.50M | 191.70M | 63.55M | 44.41M |
Common stock | 0.16M | 0.16M | 0.15M | 0.07M | 0.07M |
Capital stock | 0.16M | 0.16M | 0.15M | 0.07M | 0.07M |
Retained earnings | -15008.28700M | -1421.45400M | -992.66100M | -507.52500M | -408.66100M |
Other liab | 56.43M | 81.10M | 106.17M | 33.22M | 38.63M |
Good will | 1073.19M | 14504.17M | 14581.25M | 746.08M | 737.20M |
Other assets | 48.54M | 20.70M | 0.00209M | 6.54M | 1.40M |
Cash | 918.18M | 893.48M | 733.32M | 514.35M | 423.99M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 399.77M | 331.01M | 332.65M | 90.18M | 62.44M |
Current deferred revenue | 90.46M | 75.57M | 52.36M | 12.47M | 7.65M |
Net debt | 655.15M | 373.96M | 731.97M | -48.94900M | -9.30600M |
Short term debt | 13.59M | 12.69M | 42.56M | 5.09M | 2.61M |
Short long term debt | - | - | 42.56M | - | - |
Short long term debt total | 1573.33M | 1267.44M | 1465.29M | 465.40M | 414.68M |
Other stockholder equity | 17358.65M | 17473.34M | 16857.80M | 1538.72M | 1434.78M |
Property plant equipment | 29.64M | 74.01M | 28.55M | 10.30M | 10.15M |
Total current assets | 1315.39M | 1225.44M | 1059.61M | 588.00M | 532.74M |
Long term investments | - | - | - | - | - |
Net tangible assets | -556.08600M | -368.69500M | -665.24700M | 67.49M | 28.53M |
Short term investments | 0.00000M | 2.54M | 53.24M | 2.71M | 54.55M |
Net receivables | 210.55M | 168.96M | 169.28M | 56.95M | 43.57M |
Long term debt | 1535.29M | 1225.67M | 1379.59M | 440.41M | 414.68M |
Inventory | 56.34M | 73.08M | 56.50M | - | - |
Accounts payable | 47.69M | 47.26M | 46.03M | 9.07M | 7.77M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -42.77600M | -6.28500M | 18.52M | -17.23900M | -13.07000M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | 0.16M | 0.16M | 0.15M | 0.07M | 0.07M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | -15008.28700M | -1421.45400M | -992.66100M | -507.52500M | -408.66100M |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 48.54M | 20.70M | 18.36M | 6.54M | 1.40M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 3029.97M | 16509.17M | 16695.67M | 1014.83M | 996.14M |
Capital lease obligations | 38.04M | 41.77M | 43.14M | 30.08M | - |
Long term debt total | 1535.29M | 1225.67M | 1379.59M | 440.41M | 414.68M |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Investments | 2.51M | 60.90M | 2.50M | 47.10M | 27.82M |
Change to liabilities | 5.03M | 21.74M | -37.78500M | 6.09M | 8.83M |
Total cashflows from investing activities | -167.74300M | -72.98100M | -590.97500M | 25.01M | -257.49600M |
Net borrowings | -3.14700M | -0.91400M | 965.93M | 850.87M | 279.16M |
Total cash from financing activities | 6.50M | 40.95M | 859.14M | 35.09M | 645.61M |
Change to operating activities | -31.24600M | -35.06200M | 25.58M | 14.82M | 10.19M |
Net income | -13659.53100M | -428.79300M | -485.13600M | -98.86400M | -97.08400M |
Change in cash | 24.70M | 160.16M | 218.97M | 90.36M | 381.17M |
Begin period cash flow | 893.48M | 733.32M | 514.35M | 423.99M | 42.82M |
End period cash flow | 918.18M | 893.48M | 733.32M | 514.35M | 423.99M |
Total cash from operating activities | 189.29M | 193.99M | -53.51100M | 29.87M | -4.86000M |
Issuance of capital stock | - | - | - | 0.00000M | 330.84M |
Depreciation | 270.64M | 219.62M | 78.09M | 44.95M | 35.60M |
Other cashflows from investing activities | -153.77000M | 8.71M | -589.44700M | -18.57700M | -281.30800M |
Dividends paid | - | - | - | - | - |
Change to inventory | 14.80M | -19.49400M | -24.73200M | 10.28M | 1.71M |
Change to account receivables | -61.64100M | -17.51000M | -21.09100M | -15.88400M | -10.93100M |
Sale purchase of stock | 12.38M | 42.59M | 59.04M | 36.66M | 364.73M |
Other cashflows from financing activities | 0.61M | 41.09M | 1097.29M | 35.09M | 314.77M |
Change to netincome | 13635.81M | 453.49M | 399.73M | 58.50M | 38.27M |
Capital expenditures | 172.76M | 63.93M | 26.04M | 10.90M | 8.41M |
Change receivables | -61.64100M | -17.51000M | -21.09100M | -15.88400M | -10.93100M |
Cash flows other operating | -1.19500M | 84.29M | 46.00M | 80.02M | 20.45M |
Exchange rate changes | - | - | - | - | -2.08400M |
Cash and cash equivalents changes | 28.05M | 161.96M | 214.65M | 89.98M | 381.17M |
Change in working capital | -60.97100M | -50.32400M | -90.48300M | -0.15600M | -1.13000M |
Stock based compensation | 217.85M | 302.59M | 475.53M | 66.70M | 43.77M |
Other non cash items | 13429.14M | 109.10M | 58.65M | 28.10M | 16.23M |
Free cash flow | 16.53M | 130.06M | -79.55300M | 18.97M | -13.26700M |
Sector: Healthcare Industry: Health Information Services
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
TDOC Teladoc Inc |
-0.4 2.91% | 13.33 | - | 357.14 | 1.36 | 1.48 | 1.53 | -1.0757 |
GEHC GE HealthCare Technologies Inc. |
-0.77 0.89% | 85.95 | 22.39 | 17.33 | 1.78 | 4.79 | 2.18 | 11.79 |
VEEV Veeva Systems Inc Class A |
-1.43 0.71% | 199.09 | 54.61 | 33.22 | 12.83 | 6.73 | 11.14 | 58.84 |
MTHRF M3 Inc |
- -% | 14.60 | 29.72 | 25.00 | 0.05 | 4.38 | 0.04 | 0.12 |
MTHRY M3 Inc |
-0.1199 1.98% | 5.95 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its that licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
2 Manhattanville Road, Purchase, NY, United States, 10577
Name | Title | Year Born |
---|---|---|
Mr. Jason Nathanial Gorevic | CEO & Director | 1972 |
Ms. Mala Murthy | Chief Financial Officer | 1964 |
Mr. Adam Christian Vandervoort | Chief Legal Officer & Sec. | 1975 |
Mr. Andrew Turitz | Sr. VP of Corp. Devel. | 1973 |
Mr. Claus Torp Jensen Ph.D. | Chief Innovation Officer | NA |
Dr. George Byron Brooks | Co-Founder | NA |
Mr. Mike Waters | Chief Operating Officer | NA |
Mr. Richard J. Napolitano | Sr. VP, Chief Accounting Officer & Controller | 1967 |
Mr. Patrick Thomas Feeley C.F.A., CPA | VP of Investor Relations | NA |
Ms. Courtney Kraemer McLeod | Director of Communication | NA |
Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).